Treatment of Older AML in 2021 - May 6

May 6, 2021

Review the treatment options and recently approved therapies for older patients with AML

Target Audience

Medical Oncologists throughout the UPMC Hillman Cancer Center Network

Learning Objectives

  • Describe the recently approved therapies for older patients with AML who are not fit for induction chemotherapy
  • Identify challenges in management and review recommendations to address these obstacles
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
03/09/2021
Course expires: 
06/03/2021
Event starts: 
05/06/2021 - 4:00pm EDT
Event ends: 
05/06/2021 - 5:00pm EDT
Add to calendar: 

Treatment of Older AML in 2021

 

Thursday, May 6, 2021

4:00pm-5:00pm

 

Annie Im, MD

Pittsburgh, PA
United States

Annie Im, MD

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

The University of Pittsburgh designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register to take this course.